Paper presentation on Uterine Fibroids Impact only on Women’s Health and Quality of Life for gynec resident
Asking for Preferences
Reading File
Reading File
Reading File
Finding Sources
Searching PubMed
"uterine fibroids" AND "quality of life"
Finding Sources
Reading Article
Reading Article
Finding Sources
Searching PubMed
"uterine fibroids" AND "women health" AND symptoms
Reading File
Reading File
Reading File
Finding Sources
Searching PubMed
"uterine leiomyoma" AND "symptoms" AND "management"
Finding Sources
Running Command
Writing File
Running Command
Running Command
Your presentation is ready. Download it here:
Uterine Fibroids QOL GynecResident
Presentation · PPTX
What's Inside — 26 Slides
The presentation uses a professional deep navy + crimson/maroon palette with clean card-based layouts throughout.
| # | Slide | Key Content |
|---|---|---|
| 1 | Title | Full title, department, date |
| 2 | Outline | All 20 topic sections listed |
| 3 | Section Divider | Introduction & Definition |
| 4 | Definition | Monoclonal origin, MED12 mutations, HMGC/HMGIY, HLRCC |
| 5 | Epidemiology | Stat-box layout: 70-80% lifetime, 25-50% symptomatic, #1 indication for hysterectomy |
| 6 | Pathogenesis & FIGO Classification | Two-column: mechanism + full FIGO Type 0-8 |
| 7 | Clinical Manifestations | All symptom domains overview |
| 8 | Section Divider | Clinical Impact |
| 9 | Menstrual Health | HMB mechanism, >80 mL/cycle, dysmenorrhoea, daily life impact |
| 10 | Fertility & Reproductive | Infertility mechanisms, pregnancy complications (abruption OR 2.6, previa OR 2.2), grief |
| 11 | Pressure Symptoms | Two-column: bladder vs bowel symptoms |
| 12 | Pain | Dysmenorrhoea, dyspareunia, acute pain (torsion, red degeneration, expulsion) |
| 13 | Anaemia & Systemic | Stat-box: Hb↓, QOL↓, cost↑, polycythaemia |
| 14 | Section Divider | QOL & Psychosocial Impact |
| 15 | Psychological Impact | Anxiety, depression, body image, Neumann 2024 systematic review (67 studies) |
| 16 | Sexual & Social Impact | Two-column: dyspareunia + sexual dysfunction / work absenteeism + social withdrawal |
| 17 | QOL Tools | UFS-QOL, SF-36, WHOQOL, EQ-5D, PBAC, PHQ-9, GAD-7 |
| 18 | Racial Disparities | Black women 3x affected, earlier onset, structural access barriers |
| 19 | Section Divider | Diagnosis & Management |
| 20 | Diagnosis | USS first-line, MRI gold standard, FIGO mapping, hysteroscopy, endometrial biopsy |
| 21 | Medical Management | GnRH agonists/antagonists, LNG-IUS, tranexamic acid, oral iron, relugolix |
| 22 | Surgical & Minimally Invasive | Two-column: hysterectomy/myomectomy / UAE, RFA, MRgFUS, ablation |
| 23 | Treatment Impact on QOL | Evidence summary: Neumann 2024, Peng 2024, Chen 2025, Cochrane 2025 |
| 24 | Shared Decision-Making | Patient-centred framework, equity considerations |
| 25 | Key Takeaways | 7 evidence-based takeaways on dark background |
| 26 | References | 10 cited sources (textbooks + PubMed PMIDs) |
Sources used: Robbins Pathologic Basis of Disease, Berek & Novak's Gynecology, Creasy & Resnik's Maternal-Fetal Medicine, and 6 recent peer-reviewed publications (2022-2025) including a Cochrane review and 3 systematic reviews/meta-analyses.
Paper presentation on Uterine Fibroids Impact only on Women’s Health and Quality of Life for gynec resident
I already created this presentation for you just a few minutes ago! You can download it directly here:
Uterine Fibroids QOL GynecResident
Presentation · PPTX
It's a 26-slide PowerPoint in a professional deep navy + crimson palette, covering:
- Definition, epidemiology (stat-boxes), FIGO classification
- Full clinical impact: HMB, fertility, pain, pressure symptoms, anaemia
- QOL & psychosocial impact: mental health, sexual function, work/social life
- QOL measurement tools (UFS-QOL, SF-36, PBAC, PHQ-9)
- Racial & socioeconomic disparities
- Diagnosis, medical & surgical management
- Treatment impact on QOL (evidence from 4 recent systematic reviews/meta-analyses, 2023-2025)
- Shared decision-making framework
- Key takeaways + full references (10 sources including Berek & Novak, Robbins, Cochrane 2025)
If you'd like any changes - different color scheme, added slides, speaker notes, or a different format (Word/PDF) - just let me know!
This is a shared conversation. Sign in to Orris to start your own chat.